Skip Nav Destination
Issues
1 June 2017
-
Cover Image
Cover Image
The cover shows patients with primary breast cancer colocalization of VEGF-A expression (red) and a systemically injected near-infrared fluorescent tracer bevacizumab-IRDye800CW (green) through Multiplex Advanced Pathology Imaging (MAPI). For details, see the article by Lamberts and colleagues on page 2730 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
CCR Pediatric Oncology Series: Articles from the AACR Childhood Cancer Predisposition Workshop
Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders
Michael F. Walsh; Vivian Y. Chang; Wendy K. Kohlmann; Hamish S. Scott; Christopher Cunniff; Franck Bourdeaut; Jan J. Molenaar; Christopher C. Porter; John T. Sandlund; Sharon E. Plon; Lisa L. Wang; Sharon A. Savage
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Christian P. Kratz; Maria Isabel Achatz; Laurence Brugières; Thierry Frebourg; Judy E. Garber; Mary-Louise C. Greer; Jordan R. Hansford; Katherine A. Janeway; Wendy K. Kohlmann; Rose McGee; Charles G. Mullighan; Kenan Onel; Kristian W. Pajtler; Stefan M. Pfister; Sharon A. Savage; Joshua D. Schiffman; Katherine A. Schneider; Louise C. Strong; D. Gareth R. Evans; Jonathan D. Wasserman; Anita Villani; David Malkin
Highlights of This Issue
CCR Focus
Clinical Trial Brief Report
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants
Yogesh S. Jethava; Alan Mitchell; Joshua Epstein; Maurizio Zangari; Shmuel Yaccoby; Erming Tian; Sarah Waheed; Rashid Khan; Xenofon Papanikolaou; Monica Grazziutti; Michele Cottler-Fox; Nathan Petty; Douglas Steward; Susan Panozzo; Clyde Bailey; Antje Hoering; John Crowley; Jeffrey Sawyer; Gareth Morgan; Bart Barlogie; Frits van Rhee
Cancer Therapy: Clinical
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
Bryan J. Schneider; Manish A. Shah; Kelsey Klute; Allyson Ocean; Elizabeta Popa; Nasser Altorki; Michael Lieberman; Andrew Schreiner; Rhonda Yantiss; Paul J. Christos; Romae Palmer; Daoqi You; Agnes Viale; Pouneh Kermani; Joseph M. Scandura
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Katherine E. Poruk; Amanda L. Blackford; Matthew J. Weiss; John L. Cameron; Jin He; Michael Goggins; Zeshaan A. Rasheed; Christopher L. Wolfgang; Laura D. Wood
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisin M. Connolly; Huili Li; Rachel C. Jankowitz; Zhe Zhang; Michelle A. Rudek; Stacie C. Jeter; Shannon A. Slater; Penny Powers; Antonio C. Wolff; John H. Fetting; Adam Brufsky; Richard Piekarz; Nita Ahuja; Peter W. Laird; Hui Shen; Daniel J. Weisenberger; Leslie Cope; James G. Herman; George Somlo; Agustin A. Garcia; Peter A. Jones; Stephen B. Baylin; Nancy E. Davidson; Cynthia A. Zahnow; Vered Stearns
Author Choice
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data
Ivana Bozovic-Spasojevic; Dimitrios Zardavas; Sylvain Brohée; Lieveke Ameye; Debora Fumagalli; Felipe Ades; Evandro de Azambuja; Yacine Bareche; Martine Piccart; Marianne Paesmans; Christos Sotiriou
Personalized Medicine and Imaging
Author Choice
Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer
Heath D. Skinner; Uma Giri; Liang P. Yang; Manish Kumar; Ying Liu; Michael D. Story; Curtis R. Pickering; Lauren A. Byers; Michelle D. Williams; Jing Wang; Li Shen; Suk Y. Yoo; You Hong Fan; David P. Molkentine; Beth M. Beadle; Raymond E. Meyn; Jeffrey N. Myers; John V. Heymach
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma
Matthew E. Spector; Assuntina G. Sacco; Emily Bellile; Jeremy M.G. Taylor; Tamara Jones; Kan Sun; William C. Brown; Andrew C. Birkeland; Carol R. Bradford; Gregory T. Wolf; Mark E. Prince; Jeffrey S. Moyer; Kelly Malloy; Paul Swiecicki; Avraham Eisbruch; Jonathan B. McHugh; Douglas B. Chepeha; Laura Rozek; Francis P. Worden
Author Choice
Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
Laetitia E. Lamberts; Maximillian Koch; Johannes S. de Jong; Arthur L.L. Adams; Jürgen Glatz; Mariëtte E.G. Kranendonk; Anton G.T. Terwisscha van Scheltinga; Liesbeth Jansen; Jakob de Vries; Marjolijn N. Lub-de Hooge; Carolien P. Schröder; Annelies Jorritsma-Smit; Matthijs D. Linssen; Esther de Boer; Bert van der Vegt; Wouter B. Nagengast; Sjoerd G. Elias; Sabrina Oliveira; Arjen J. Witkamp; Willem P.Th.M. Mali; Elsken Van der Wall; Paul J. van Diest; Elisabeth G.E. de Vries; Vasilis Ntziachristos; Gooitzen M. van Dam
Cancer Therapy: Preclinical
Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer
Sarah R. Hosford; Lloye M. Dillon; Stephanie J. Bouley; Rachele Rosati; Wei Yang; Vivian S. Chen; Eugene Demidenko; Rocco P. Morra, Jr; Todd W. Miller
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
Wilhem Leconet; Myriam Chentouf; Stanislas du Manoir; Clément Chevalier; Audrey Sirvent; Imade Aït-Arsa; Muriel Busson; Marta Jarlier; Nina Radosevic-Robin; Charles Theillet; Dany Chalbos; Jean-Max Pasquet; André Pèlegrin; Christel Larbouret; Bruno Robert
Author Choice
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion
Sinnie Sin Man Ng; Bethany A. Nagy; Shawn M. Jensen; Xintao Hu; Candido Alicea; Bernard A. Fox; Barbara K. Felber; Cristina Bergamaschi; George N. Pavlakis
The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia
Sarah E.M. Herman; Arnau Montraveta; Carsten U. Niemann; Helena Mora-Jensen; Michael Gulrajani; Fanny Krantz; Rose Mantel; Lisa L. Smith; Fabienne McClanahan; Bonnie K. Harrington; Dolors Colomer; Todd Covey; John C. Byrd; Raquel Izumi; Allard Kaptein; Roger Ulrich; Amy J. Johnson; Brian J. Lannutti; Adrian Wiestner; Jennifer A. Woyach
Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
Andrew C. Wood; Kateryna Krytska; Hannah T. Ryles; Nicole R. Infarinato; Renata Sano; Theodore D. Hansel; Lori S. Hart; Frederick J. King; Timothy R. Smith; Edward Ainscow; Kathryn B. Grandinetti; Tove Tuntland; Sunkyu Kim; Giordano Caponigro; You Qun He; Shiva Krupa; Nanxin Li; Jennifer L. Harris; Yaël P. Mossé
Biology of Human Tumors
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck; Francesca Fanini; Tetsuro Setoyama; Cristina Ivan; Cristian Rodriguez-Aguayo; Enrique Fuentes-Mattei; Lianchun Xiao; Ivan Vannini; Roxana S. Redis; Lucilla D'Abundo; Xinna Zhang; Milena S. Nicoloso; Simona Rossi; Vianey Gonzalez-Villasana; Rajesha Rupaimoole; Manuela Ferracin; Fortunato Morabito; Antonino Neri; Peter P. Ruvolo; Vivian R. Ruvolo; Chad V. Pecot; Dino Amadori; Lynne Abruzzo; Steliana Calin; Xuemei Wang; M. James You; Alessandra Ferrajoli; Robert Orlowski; William Plunkett; Tara M. Lichtenberg; Ramana V. Davuluri; Ioana Berindan-Neagoe; Massimo Negrini; Ignacio I. Wistuba; Hagop M. Kantarjian; Anil K. Sood; Gabriel Lopez-Berestein; Michael J. Keating; Muller Fabbri; George A. Calin
Author Choice
microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma
Xiao-yan He; Zheng-lan Tan; Qin Mou; Fang-jie Liu; Shan Liu; Chao-wen Yu; Jin Zhu; Lin-ya Lv; Jun Zhang; Shan Wang; Li-ming Bao; Bin Peng; Hui Zhao; Lin Zou
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.